Enanta Pharma (ENTA) Misses Q1 EPS by 16c, Revenues Miss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rises after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| ENANTA PHARM (NASDAQ: ENTA) | Delayed: 10.73 +0.36 (3.47%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.37 | 52 Week High | $34.49 | |||
| Open | $10.62 | 52 Week Low | $20.39 | |||
| Day High | $10.85 | P/E | N/A | |||
| Day Low | $10.26 | EPS | $-3.18 | |||
| Volume | 169,607 | |||||
